Antibody data
- Antibody Data
- Antigen structure
- References [8]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 16026-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- BCL2L2 antibody
- Antibody type
- Polyclonal
- Description
- BCL2L2 antibody (Cat. #16026-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IHC, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Mechanism of piR-1245/PIWI-like protein-2 regulating Janus kinase-2/signal transducer and activator of transcription-3/vascular endothelial growth factor signaling pathway in retinal neovascularization.
Gemcitabine Cooperates with Everolimus to Inhibit the Growth of and Sensitize Malignant Meningioma Cells to Apoptosis Induced by Navitoclax, an Inhibitor of Anti-Apoptotic BCL-2 Family Proteins.
Targeting anti-apoptotic pathways eliminates senescent melanocytes and leads to nevi regression.
GSK-3β-mediated activation of NLRP3 inflammasome leads to pyroptosis and apoptosis of rat cardiomyocytes and fibroblasts.
Peptides Isolated from Yak Milk Residue Exert Antioxidant Effects through Nrf2 Signal Pathway.
HNRNPA2B1 as a trigger of RNA switch modulates the miRNA-mediated regulation of CDK6.
MicroRNA-15a induces cell apoptosis and inhibits metastasis by targeting BCL2L2 in non-small cell lung cancer.
Silencing prion protein in MDA-MB-435 breast cancer cells leads to pleiotropic cellular responses to cytotoxic stimuli.
Yu Y, Xia LK, Di Y, Nie QZ, Chen XL
Neural regeneration research 2023 May;18(5):1132-1138
Neural regeneration research 2023 May;18(5):1132-1138
Gemcitabine Cooperates with Everolimus to Inhibit the Growth of and Sensitize Malignant Meningioma Cells to Apoptosis Induced by Navitoclax, an Inhibitor of Anti-Apoptotic BCL-2 Family Proteins.
Yamamoto M, Suzuki S, Togashi K, Sugai A, Okada M, Kitanaka C
Cancers 2022 Mar 27;14(7)
Cancers 2022 Mar 27;14(7)
Targeting anti-apoptotic pathways eliminates senescent melanocytes and leads to nevi regression.
Kohli J, Ge C, Fitsiou E, Doepner M, Brandenburg SM, Faller WJ, Ridky TW, Demaria M
Nature communications 2022 Dec 23;13(1):7923
Nature communications 2022 Dec 23;13(1):7923
GSK-3β-mediated activation of NLRP3 inflammasome leads to pyroptosis and apoptosis of rat cardiomyocytes and fibroblasts.
Wang SH, Cui LG, Su XL, Komal S, Ni RC, Zang MX, Zhang LR, Han SN
European journal of pharmacology 2022 Apr 5;920:174830
European journal of pharmacology 2022 Apr 5;920:174830
Peptides Isolated from Yak Milk Residue Exert Antioxidant Effects through Nrf2 Signal Pathway.
Yang F, He X, Chen T, Liu J, Luo Z, Sun S, Qin D, Huang W, Tang Y, Liu C, Luo F
Oxidative medicine and cellular longevity 2021;2021:9426314
Oxidative medicine and cellular longevity 2021;2021:9426314
HNRNPA2B1 as a trigger of RNA switch modulates the miRNA-mediated regulation of CDK6.
Yin M, Cheng M, Liu C, Wu K, Xiong W, Fang J, Li Y, Zhang B
iScience 2021 Nov 19;24(11):103345
iScience 2021 Nov 19;24(11):103345
MicroRNA-15a induces cell apoptosis and inhibits metastasis by targeting BCL2L2 in non-small cell lung cancer.
Yang T, Thakur A, Chen T, Yang L, Lei G, Liang Y, Zhang S, Ren H, Chen M
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2015 Jun;36(6):4357-65
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2015 Jun;36(6):4357-65
Silencing prion protein in MDA-MB-435 breast cancer cells leads to pleiotropic cellular responses to cytotoxic stimuli.
Yu G, Jiang L, Xu Y, Guo H, Liu H, Zhang Y, Yang H, Yuan C, Ma J
PloS one 2012;7(11):e48146
PloS one 2012;7(11):e48146
No comments: Submit comment
No validations: Submit validation data